EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 29-Dec-2025 20:11 ET (30-Dec-2025 01:11 GMT/UTC)

9-Sep-2025

Lung Cancer Europe study highlights communication gaps and need for shared decision-making

International Association for the Study of Lung Cancer
Reports and Proceedings

A large-scale survey conducted by Lung Cancer Europe (LuCE) has identified critical communication barriers that affect information access, understanding, and shared decision-making among lung cancer patients and caregivers across Europe. The research was reported at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC).

8-Sep-2025

Study used AI models to improve prediction of chronic kidney disease progression to end stage renal disease

Carnegie Mellon University
Peer-Reviewed Publication

In a new study, researchers used machine learning and deep learning models, as well as explainable artificial intelligence (AI), to assess integrated clinical and claims data with the goal of improving prediction of CKD’s progression to ESRD. The integrated models outperformed single data source models, which can enhance CKD management, support targeted interventions, and reduce health-care disparities.

8-Sep-2025

Compact genetic light switches transform disease control

Texas A&M University
Peer-Reviewed Publication

Researchers have created new light-controlled tools that respond to blue light with pinpoint accuracy, offering safer, more precise treatments in the future.

Journal: Nature Communications
Funder: NIH/National Institutes of Health, Welch Foundation, Cancer Prevention and Research Institute of Texas, Alkek Early Career Fellowship, Leukemia and Lymphoma Society

8-Sep-2025

Lung cancer genetics study launches open-source data platform to research community

23andMe Research Institute
Business Announcement

At the 2025 World Conference on Lung Cancer in Barcelona, the 23andMe Research Institute, in collaboration with Troper Wojcicki Philanthropies and the health data software company Lifebit, introduced an open source platform that could help fast-track research discoveries through a powerful new cancer data repository. Access to this powerful new tool is FREE to qualified researchers.

8-Sep-2025

Resistance mutations and the blood–brain barrier: Key challenges in targeted treatment of brain metastatic non-small cell lung cancer

Compuscript Ltd
Peer-Reviewed Publication

https://doi.org/10.1016/j.apsb.2025.06.002

This new article publication from Acta Pharmaceutica Sinica B, discusses key challenges in targeted treatment of brain metastatic non-small cell lung cancer.

Journal: Acta Pharmaceutica Sinica B

8-Sep-2025

How does chemotherapy disrupt circadian rhythms?

Society for Neuroscience
Peer-Reviewed Publication

Using female mice, researchers find that a frequently used breast cancer treatment impairs molecular and behavioral measures of the primary biological clock found in the brain.

Journal: eNeuro
Funder: NIH/National Cancer Institute

8-Sep-2025

IU scientists reprogram cancer-protecting regulatory T cells to fight tumors

Indiana University
Peer-Reviewed Publication

A new method developed by IU School of Medicine researchers changes the behavior of immunosuppressive cells from cancer protectors to tumor fighters.

Journal: Science Immunology

8-Sep-2025

Cancer cells can use backup routes to fuel their growth

Van Andel Research Institute
Peer-Reviewed Publication

A new study by Van Andel Institute scientists suggest that the routes cancer cells use to process different nutrients deeply influence cell behavior. They discovered an alternate, or non-canonical, path by which cancer cells convert a ketone called β-hydroxybutyrate (β-OHB) into acetyl-CoA, an essential metabolic building block for fatty acids and cholesterol that supports cell proliferation. The findings, published today in the journal Nature Metabolism, could reshape how the relationship between diet and cancer is viewed.

Journal: Nature Metabolism
Funder: NIH/National Cancer Institute, NIH/National Cancer Institute, NIH/National Institute of Allergy and Infectious Diseases, Van Andel Institute Metabolism & Nutrition (MeNu) Program, Canadian Institutes of Health Research

8-Sep-2025

Tarlatamab with anti-PD-L1 as first-line maintenance after chemo-immunotherapy for ES-SCLC demonstrates acceptable safety profile and unprecedented overall survival

International Association for the Study of Lung Cancer
Reports and Proceedings

Clinical data presented today demonstrates the combination of tarlatamab with anti-PD-L1 therapy as first-line maintenance has an acceptable safety profile and resulted in unprecedented overall survival in patients with extensive-stage small cell lung cancer (ES-SCLC).

8-Sep-2025

Moffitt develops first genetically engineered cancer model in naked mole rats

H. Lee Moffitt Cancer Center & Research Institute
Peer-Reviewed Publication

Researchers at Moffitt Cancer Center have created the first genetically engineered model of lung cancer in naked mole rats, a species long thought to be resistant to cancer. The findings, published in Cancer Discovery, shed light on how cancer begins in this unusual rodent and may reveal new parallels to tumor development in humans.

Journal: Cancer Discovery
Funder: NIH/National Institutes of Health